NCT00691652 2019-11-27
Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma
OHSU Knight Cancer Institute
Phase 1/2 Terminated
OHSU Knight Cancer Institute
Mayo Clinic
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
Case Comprehensive Cancer Center